Results 81 to 90 of about 1,036 (190)

Sport-Specific Use of Doping Substances: Analysis of World Anti-Doping Agency Doping Control Tests between 2014 and 2017. [PDF]

open access: yes, 2020
Background: In recent years, there has been a solid effort across all sports organizations to reduce the prevalence and incidence of doping in sport.
Aguilar Navarro, Millán   +4 more
core   +1 more source

Влияние медикаментозной терапии на клиническое и психоэмоциональное состояние больных с хронической сердечной недостаточностью и сохраненной фракцией выброса [PDF]

open access: yes, 2018
На сегодняшний день отсутствуют результаты исследований, демонстрирующие снижение смертности на фоне лечения больных с хронической сердечной недостаточностью (ХСН) и сохраненной фракцией выброса, при этом данный синдром остается ведущей причиной ...
Вихрова, Т.А.   +3 more
core  

biobibliogrāfija II [PDF]

open access: yes, 2015
Latvijas Zinātņu akadēmijas akadēmiķe profesore Vija Zaiga Kluša : biobibliogrāfija II / Latvijas Universitātes Akadēmiskā bibliotēka; sast. Dagnija Ivbule; korektore Gita Bērziņa; maketu veidojusi Baiba Lazdiņa.
Ivbule, Dagnija   +1 more
core  

Simultaneous Determination of Clomiphene, Trimetazidine and Meldonium in Foods by Ultra-high Performance Liquid Chromatography-Tandem Mass Spectrometry Combined with Pass-Through Solid Phase Extraction [PDF]

open access: yesShipin Kexue
In this study, we established a method for the determination of three metabolic regulators including clomiphene, trimetazidine and meldonium in foods by pass-through solid phase extraction combined with ultra-high performance liquid chromatography-tandem
SONG Juan, LI Jun, ZHANG Yangyang, YAO Leijun, XIAO Quanwei, LI Shaobo, DAI Qin
doaj   +1 more source

Аденозинтрифосфорная кислота в крови как маркер состояния энергетического обмена миокарда при оценке энергосберегающих эффектов метаболических корректоров [PDF]

open access: yes, 2017
Целью исследования явилось определение адекватного маркера состо­яния энергетического обмена миокарда для оценки энергосберегающих эффектов метабо­лических корректоров при экспериментальной ишемии ...
Горбач, Т. В.   +4 more
core  

Correction of retinal ischemia/reperfusion by 3-(1H-benzimidazol-2-il)-1,2,2-trimethyl cyclopentancarbonic acid in experiment [PDF]

open access: yes, 2018
Results of ocular fundus studies revealed the most pronounced protective effects of 3-(1Hbenzimidazol-2-il)-1,2,2-trimethyl cyclopentancarbonic acid in a dose 50 mg/kg on the model of retinal ischemiareperfusion in Wistar rats, which is reflected in the ...
Bunyatyan, N. D.   +4 more
core  

Letter to Editor: Potential Use of Meldonium as Supportive Treatment in Lifestyle Diseases

open access: yesJournal of Education, Health and Sport
Meldonium, a drug more familiar in the sports world than in clinical medicine, acts as a structural analog of gamma-butyrobetaine and influences carnitine metabolism by inhibiting gamma-butyrobetaine hydroxylase. This results in reduced carnitine levels,
Magdalena Grzesiak, Oskar Szymański
doaj   +1 more source

Studying the Efficacy of Vazonat in Comprehensive Treatment of Patients with Diabetes Mellitus Type 2

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2016
The objective — to study the effectiveness of Vazonat (meldonium) in patients with diabetes mellitus (DM) type 2 in the comparative 12-week study. Materials and methods. The study involved 55 patients with DM type 2.
V.I. Pankiv
doaj   +1 more source

Meldonium: dotychczasowe i nowe możliwości terapeutyczne

open access: yesPostępy Biochemii
Meldonium functions as an inhibitor of γ-butyrobetaine hydroxylase, the enzyme responsible for catalyzing the biosynthesis of L-carnitine. By inhibiting mitochondrial β-oxidation of fatty acids under hypoxic conditions, meldonium exerts cytoprotective effects on cardiac, hepatic, and pulmonary tissues.
Halszka Ponamarczuk, Marcin Popielarski
openaire   +1 more source

Experience with mildronate in cerebrovascular diseases

open access: yesМедицинский совет, 2015
Over the past years, results of various clinical trials of drugs demonstrating their efficacy in the treatment of cardiovascular diseases have been published. The article discusses the results of clinical use of Mildronate (meldonium) in the treatment of
N. V. Pizova
doaj   +1 more source

Home - About - Disclaimer - Privacy